Conference abstract · 17 Aug 2015
Conference abstract
Paclitaxel loaded cationic solid lipid nanoparticle formulation, preparation and evaluation
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Now a days one of the most important health problem is cancer which is characterized by uncontrolled cellular proliferation. Paclitaxel is a mitotic inhibitor used in cancer chemotherapy; it represent the taxane family of drugs. Paclitaxel?s mechanism of action involves its stabilization of cellular microtubules; as a result, it interferes with the normal breakdown of microtubules during cell division. It is effect on the proliferation of tumor cells suppression with by prevent the vascularisation (angiogenesis), cell migration and collagen formation. Therefore, Paclitaxel is used commonly for treatment of lung, ovarian, breast, and head and neck cancers in therapy. Solid lipid nanoparticles (SLNs) were introduced at the beginning of the 1990?s as an alternative to traditional delivery systems such as emulsions, liposomes and polymeric systems. SLNs are nano-sized particles prepared using lipids which are solid at room and body temperatures and which can be stabilized with surfactants. The lipids used are biocompatible compounds with GRAS feature. The objective of this study was to formulate biodegradable and biocompatible cationic lipid delivery systems which is loaded Paclitaxel. After evaluation of the particle size, surface charge and the degree of crystallinity of formulation, cell culture studies were performed for the determination of cytotoxic effects. Colorimetric MTT method was used for the quantitative determination of cell cytotoxicity and MDA and MCF-7 cells were used.
Keywords
Subjects
NanotechnologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract
Formulation and evaluation of linagliptin loaded solid lipid Nanoparticles for the treatment of type-2 Diabetes
Conference abstract · 8 Jun 2016
Rivastigmine loaded solid lipid nanoparticles: Formulation and in vitro characterization and antioxidant activity
Conference abstract · 2018
Core-shell solid lipid nanoparticles for the targeted delivery of paclitaxel: A proof-of-concept study in breast cancer cells
Research article · 2016
Haloperidol Loaded Solid Lipid Nanoparticles for Nose to Brain Delivery: Stability and In vivo Studies
More from this journal
The newest in Journal of Nanomedicine & Nanotechnology.
Article · 16 Feb 2026
Evaluation of In vitro Anticancer Activity of Poly Herbal Extract (Vitis vinifera, Nigella sativa and Curcurbita pepo Seeds)
Article · 21 Oct 2025
Green Synthesis of Chromium(III) Oxide Nanoparticles and their Evaluation against Skin Infections
Article · 19 Jun 2025
Potential of Bhasma as Nanomedicine for Disease Management: A Synopsis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nanomedicine & Nanotechnology
- SubjectNanotechnology
- BylineArticles whose byline prints “Ahmet Alper Ozturk”
- BylineArticles whose byline prints “Behiye Senel”
- BylineArticles whose byline prints “Evrim Yenilmez”
- BylineArticles whose byline prints “Ebru Basaran”
- BylineArticles whose byline prints “Gulay Buyukkoroglu”

